VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
  • A randomized, double-blind, dose-ranging, pilot trial of piperine with resveratrol on the effects on serum levels of resveratrol [Elektronski vir]
    Bailey, Howard H. ...
    Resveratrol (3,4,5-trihydroxystilbene) is a naturally occurring phytoalexin with purported health-promoting effects, but with limited oral bioavailability. Our prior murine modeling research observed ... enhanced resveratrol bioavailability with piperine co-administration. In this study, single-dose pharmacokinetics of resveratrol with or without piperine and the associated toxicities were studied on a cohort of healthy volunteers. We performed a double-blind, randomized, three-arm pilot study. Participants were randomized to receive a single dose of resveratrol 2.5 g, with piperine in 0 mg, 5 mg, or 25 mg dose. An improved liquid chromatography/mass spectrometry assay was used to determine serum levels of resveratrol and resveratrol-glucuronide. Baseline through 24 h post-study drug serum analyses were performed and adverse events were followed for 30 days. Twenty-four participants were enroled. No significant relationship between dose and pharmacokinetic values were found. In the sex stratified analysis, Cmax for resveratrol in women showed a trend (P = 0.057) toward an increase with piperine. Pharmacokinetic values for resveratrol were: Cmax % 18.5 % 16 ng/mL resveratrol alone, 29 % 29 resveratrol + 5 mg piperine, 16 % 13 resveratrol + 25 mg piperine; area under the concentration % time curve % 1270 % 852%ng/h/mL resveratrol alone, 2083 % 2284 resveratrol + 5 mg piperine, 1132 % 222 resveratrol + 25 mg piperine. All subjects tolerated their protocol therapy with minimal to no toxicity and no evidence of differences between the three groups. The co-administration of resveratrol with piperine at 5 and 25 mg doses did not sufficiently alter the pharmacokinetics of resveratrol or resveratrol-glucuronide to demonstrate the significant enhancement observed in murine modeling.
    Vir: European journal of cancer prevention [Elektronski vir]. - ISSN 1473-5709 (Vol. 30, No. 3, 2021, str. 285-290)
    Vrsta gradiva - e-članek ; neleposlovje za odrasle
    Leto - 2020
    Jezik - angleški
    COBISS.SI-ID - 27089923

    Povezava(-e):

    https://journals.lww.com/eurjcancerprev/Abstract/9000/A_randomized,_double_blind,_dose_ranging,_pilot.99106.aspx
    DOI

Vnos na polico